BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 2007;66:790-7. [PMID: 17185325 DOI: 10.1136/ard.2006.065656] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Bornacelly A, Mercado D, Acevedo N, Caraballo L. The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF). BMC Immunol 2014;15:22. [PMID: 24906685 DOI: 10.1186/1471-2172-15-22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Scholzen A, Sauerwein RW. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends in Parasitology 2013;29:252-62. [DOI: 10.1016/j.pt.2013.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
3 Mariette X. How does BAFF activate B cells in patients with autoimmune diseases? Arthritis Res Ther 2012;14:106. [PMID: 22360881 DOI: 10.1186/ar3729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
4 Stergiou IE, Poulaki A, Voulgarelis M. Pathogenetic Mechanisms Implicated in Sjögren's Syndrome Lymphomagenesis: A Review of the Literature. J Clin Med 2020;9:E3794. [PMID: 33255258 DOI: 10.3390/jcm9123794] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Grammatikos AP, Tsokos GC. Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus. Trends Mol Med 2012;18:101-8. [PMID: 22177735 DOI: 10.1016/j.molmed.2011.10.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 6.2] [Reference Citation Analysis]
6 Zhu X, Shi Y, Zhang F, Yao Q, Liu Y, Shan N, Wang D, Peng J, Xu J, Hou M. Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia. Br J Haematol 2014;166:783-91. [DOI: 10.1111/bjh.12958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM. Increased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther. 2009;11:R156. [PMID: 19832990 DOI: 10.1186/ar2833] [Cited by in Crossref: 151] [Cited by in F6Publishing: 146] [Article Influence: 12.6] [Reference Citation Analysis]
8 Moura RA, Canhão H, Polido-Pereira J, Rodrigues AM, Navalho M, Mourão AF, Resende C, Campanilho-Marques R, Madruga Dias J, da Silva JA, Graca L, Fonseca JE. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis. J Rheumatol 2013;40:1293-302. [PMID: 23772083 DOI: 10.3899/jrheum.121110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
9 Mensen A, Jöhrens K, Anagnostopoulos I, Demski S, Oey M, Stroux A, Hemmati P, Westermann J, Blau O, Wittenbecher F, Movassaghi K, Szyska M, Thomas S, Dörken B, Scheibenbogen C, Arnold R, Na IK. Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT. Blood 2014;124:963-72. [PMID: 24833353 DOI: 10.1182/blood-2013-11-539031] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
10 Mariette X, Gottenberg JE. Pathogenesis of Sjögren's syndrome and therapeutic consequences. Curr Opin Rheumatol 2010;22:471-7. [PMID: 20671520 DOI: 10.1097/BOR.0b013e32833c36c5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
11 Liu L, Allman WR, Coleman AS, Takeda K, Lin TL, Akkoyunlu M. Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse. Sci Rep 2018;8:1308. [PMID: 29358664 DOI: 10.1038/s41598-018-19827-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Lei Z, Liu G, Huang Q, Lv M, Zu R, Zhang GM, Feng ZH, Huang B. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 2008;63:327-32. [PMID: 18053009 DOI: 10.1111/j.1398-9995.2007.01566.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
13 van den Hoogen LL, Palla G, Bekker CPJ, Fritsch-Stork RDE, Radstake TRDJ, van Roon JAG. Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores. RMD Open 2018;4:e000693. [PMID: 30018806 DOI: 10.1136/rmdopen-2018-000693] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Matharu K, Zarember KA, Marciano BE, Kuhns DB, Spalding C, Garofalo M, Dimaggio T, Estwick T, Huang CY, Fink D, Priel DL, Fleisher TA, Holland SM, Malech HL, Gallin JI. B-cell activating factor (BAFF) is elevated in chronic granulomatous disease. Clin Immunol 2013;148:258-64. [PMID: 23773925 DOI: 10.1016/j.clim.2013.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Nikolov NP, Illei GG. Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009;21:465-70. [PMID: 19568172 DOI: 10.1097/BOR.0b013e32832eba21] [Cited by in Crossref: 115] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
16 Thibault-Espitia A, Foucher Y, Danger R, Migone T, Pallier A, Castagnet S, G-Gueguen C, Devys A, C-Gautier A, Giral M. BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant. 2012;12:2754-2762. [PMID: 22883025 DOI: 10.1111/j.1600-6143.2012.04194.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
17 Zhang H, Xiao F, Liu Y, Zhao D, Shan Y, Jiang Y. A higher frequency of peripheral blood activated B cells in patients with non-traumatic osteonecrosis of the femoral head. Int Immunopharmacol 2014;20:95-100. [PMID: 24583150 DOI: 10.1016/j.intimp.2014.02.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
18 Allman WR, Liu L, Coleman AS, Akkoyunlu M. MRL Strains Have a BAFFR Mutation without Functional Consequence. PLoS One 2016;11:e0154518. [PMID: 27149280 DOI: 10.1371/journal.pone.0154518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Muema DM, Macharia GN, Hassan AS, Mwaringa SM, Fegan GW, Berkley JA, Nduati EW, Urban BC. Control of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected Children. J Immunol 2015;195:1082-91. [PMID: 26116511 DOI: 10.4049/jimmunol.1500491] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
20 Reina S, Sterin-Borda L, Passafaro D, Borda E. Anti-M(3) muscarinic cholinergic autoantibodies from patients with primary Sjögren's syndrome trigger production of matrix metalloproteinase-3 (MMP-3) and prostaglandin E(2) (PGE(2)) from the submandibular glands. Arch Oral Biol 2011;56:413-20. [PMID: 21371688 DOI: 10.1016/j.archoralbio.2010.08.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
21 Rozmus J, Kariminia A, Abdossamadi S, Storer BE, Martin PJ, Lee SJ, Wolff D, Arora M, Cutler C, Schultz KR. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis. Biol Blood Marrow Transplant 2019;25:451-8. [PMID: 30447393 DOI: 10.1016/j.bbmt.2018.11.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Henriques A, Silva I, Inês L, Souto-carneiro MM, Pais ML, Trindade H, da Silva JAP, Paiva A. CD38, CD81 and BAFFR combined expression by transitional B cells distinguishes active from inactive systemic lupus erythematosus. Clin Exp Med 2016;16:227-32. [DOI: 10.1007/s10238-015-0348-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
23 Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, Puéchal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Nocturne G, Ravaud P, Mariette X. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS One 2013;8:e59868. [PMID: 23717383 DOI: 10.1371/journal.pone.0059868] [Cited by in Crossref: 104] [Cited by in F6Publishing: 91] [Article Influence: 13.0] [Reference Citation Analysis]
24 Ho JW, Lin MW, Braet F, Su YY, Adelstein S, dos Remedios CG. Customising an antibody leukocyte capture microarray for systemic lupus erythematosus: beyond biomarker discovery. Proteomics Clin Appl 2010;4:179-89. [PMID: 21137042 DOI: 10.1002/prca.200900165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Barbosa RR, Silva SL, Silva SP, Melo AC, Pereira-Santos MC, Barata JT, Hammarström L, Cascalho M, Sousa AE. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol 2014;34:573-83. [PMID: 24809296 DOI: 10.1007/s10875-014-0047-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
26 Salazar-camarena DC, Ortiz-lazareno PC, Cruz A, Oregon-romero E, Machado-contreras JR, Muñoz-valle JF, Orozco-lópez M, Marín-rosales M, Palafox-sánchez CA. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 2016;25:582-92. [DOI: 10.1177/0961203315608254] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
27 Zhou Z, Zhou Z, Chen Z, Zhou Z, Chen Z, Li H, Chen X, Xu J, Gu D, Du W, Zheng C, Zhang L, Huang Y, Ren Q, Yang R. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity 2009;42:112-9. [DOI: 10.1080/08916930802397848] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
28 Lepse N, Land J, Rutgers A, Kallenberg CGM, Stegeman CA, Abdulahad WH, Heeringa P. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. Rheumatology 2015;55:162-72. [DOI: 10.1093/rheumatology/kev293] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
29 Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. Cancer Res 2010;70:4346-56. [PMID: 20460528 DOI: 10.1158/0008-5472.CAN-10-0300] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
30 Scholzen A, Teirlinck AC, Bijker EM, Roestenberg M, Hermsen CC, Hoffman SL, Sauerwein RW. BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection. J Immunol 2014;192:3719-29. [PMID: 24646735 DOI: 10.4049/jimmunol.1302960] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
31 Becerra E, De La Torre I, Leandro MJ, Cambridge G. B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets. Clin Exp Immunol 2017;190:372-83. [PMID: 28800164 DOI: 10.1111/cei.13024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
32 Yang Q, Xu S, Li X, Wang B, Wang X, Ma D, Yang L, Peng J, Hou M. Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo. PLoS One 2011;6:e22708. [PMID: 21818370 DOI: 10.1371/journal.pone.0022708] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
33 Sarantopoulos S, Stevenson KE, Kim HT, Bhuiya NS, Cutler CS, Soiffer RJ, Antin JH, Ritz J. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res. 2007;13:6107-6114. [PMID: 17947475 DOI: 10.1158/1078-0432.ccr-07-1290] [Cited by in Crossref: 173] [Cited by in F6Publishing: 93] [Article Influence: 12.4] [Reference Citation Analysis]
34 Lin W, Jin L, Chen H, Wu Q, Fei Y, Zheng W, Wang Q, Li P, Li Y, Zhang W, Zhao Y, Zeng X, Zhang F. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences. Arthritis Res Ther 2014;16:R118. [PMID: 24887143 DOI: 10.1186/ar4571] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
35 Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis Rheum 2011;63:3692-701. [PMID: 22127692 DOI: 10.1002/art.30599] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
36 [DOI: 10.1101/840389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Jiang R, Fichtner ML, Hoehn KB, Pham MC, Stathopoulos P, Nowak RJ, Kleinstein SH, O'Connor KC. Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses. JCI Insight 2020;5:136471. [PMID: 32573488 DOI: 10.1172/jci.insight.136471] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
38 Bloom D, Chang Z, Pauly K, Kwun J, Fechner J, Hayes C, Samaniego M, Knechtle S. BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant 2009;9:1835-45. [PMID: 19522878 DOI: 10.1111/j.1600-6143.2009.02710.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
39 Pontarini E, Fabris M, Quartuccio L, Cappeletti M, Calcaterra F, Roberto A, Curcio F, Mavilio D, Della Bella S, De Vita S. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2015;54:1429-34. [PMID: 25740829 DOI: 10.1093/rheumatology/kev005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
40 Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010;6:529-37. [PMID: 20683439 DOI: 10.1038/nrrheum.2010.118] [Cited by in Crossref: 151] [Cited by in F6Publishing: 127] [Article Influence: 13.7] [Reference Citation Analysis]
41 Meyer-bahlburg A, Renner ED, Rylaarsdam S, Reichenbach J, Schimke LF, Marks A, Tcheurekdjian H, Hostoffer R, Brahmandam A, Torgerson TR, Belohradsky BH, Rawlings DJ, Ochs HD. Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. Journal of Allergy and Clinical Immunology 2012;129:559-562.e2. [DOI: 10.1016/j.jaci.2011.09.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
42 Nduati E, Gwela A, Karanja H, Mugyenyi C, Langhorne J, Marsh K, Urban BC. The plasma concentration of the B cell activating factor is increased in children with acute malaria. J Infect Dis 2011;204:962-70. [PMID: 21849293 DOI: 10.1093/infdis/jir438] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
43 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Comarmond C, Garrido M, Pol S, Desbois AC, Costopoulos M, Le Garff-Tavernier M, Si Ahmed SN, Alric L, Fontaine H, Bellier B, Maciejewski A, Rosenzwajg M, Klatzmann D, Musset L, Poynard T, Cacoub P, Saadoun D. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis. Gastroenterology 2017;152:2052-2062.e2. [PMID: 28274850 DOI: 10.1053/j.gastro.2017.02.037] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
45 Proust A, Rincé P, Creidy R, Lazure T, Joab I, Garçon L, Fabre M, Guettier C, Raphael M. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. Am J Pathol 2011;179:1630-7. [PMID: 21871426 DOI: 10.1016/j.ajpath.2011.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Zhao LD, Li Y, Smith MF Jr, Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus 2010;19:1534-49. [PMID: 20974656 DOI: 10.1177/0961203310375268] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
47 London J, Dumoitier N, Lofek S, Dion J, Chaigne B, Mocek J, Thieblemont N, Cohen P, Le Jeunne C, Guillevin L, Witko-Sarsat V, Varin-Blank N, Terrier B, Mouthon L; French Vasculitis Study Group (FVSG). Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis. Rheumatology (Oxford) 2021;60:2157-68. [PMID: 33026090 DOI: 10.1093/rheumatology/keaa432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Kim J, Gross JA, Dillon SR, Min J, Elkon KB. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Autoimmunity 2011;44:69-81. [DOI: 10.3109/08916934.2010.509122] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]